Insulin resistance and hyperinsulinemia, features of type 2 diabetes, increase the bioavailability of estrogen and insulin-like growth factor (IGF)-1, which promote endometrial proliferation [48] and are conducive to the development of endometrial cancer (especially type I) [49]. This evidence concerns the gene IGF1 and hyperinsulinism.